Amazon's new pharmacy is way more expensive than one of its key rivals, showing the long road ahead for the tech giant's ambitions to disrupt the industry

<figure>
<img alt="GoodRx.JPG" class="img-responsive imported-news-entry-img" src="https://images2.markets.businessinsider.com/5eb5c83c42278d0c0a58a2d8?format=jpeg" />
<figcaption>GoodRx CEOs Doug Hirsch and Trevor Bezdek
<p class="copyright">GoodRx<!– sh_cad_1 –>
</figcaption>
</figure><ul class="summary-list">
<li>As part of Amazon…

This post was originally published on this site